Literature DB >> 11689354

Mechanisms of Bordetella pathogenesis.

S Mattoo1, A K Foreman-Wykert, P A Cotter, J F Miller.   

Abstract

Bordetella are Gram negative bacteria that cause respiratory tract infections in humans and animals. While at least five different species of Bordetella are known to exist, this review focuses on B. pertussis, B. bronchiseptica and B. parapertussis subspecies. In their virulent phase, all of these bacteria produce a nearly identical set of virulence factors which include adhesins such as filamentous hemagglutinin (FHA), fimbriae and pertactin, as well as toxins such as a bifunctional adenylate cyclase/hemolysin, dermonecrotic toxin, tracheal cytotoxin, a B. pertussis specific pertussis toxin and B. bronchiseptica specific type III secreted proteins. Expression of nearly all of these virulence factors is positively regulated by the products of the bvgAS locus. BvgA and BvgS comprise a two-component signal transduction system that mediates transition between at least three identifiable phases---a virulent (Bvg+) phase, an avirulent (Bvg-) phase and an intermediate (Bvg(i)) phase---in response to specific environmental signals. Bordetella colonize the ciliated respiratory mucosa, a surface designed to eliminate foreign particles, thereby making the adherence and persistence mechanisms of these bacteria crucial. The development of relevant animal models for B. bronchiseptica has enabled us to study Bordetella pathogenesis in the context of natural host-pathogen interactions. In addition, evolutionary studies across the various Bordetella species and detailed analysis of differential regulation of Bvg-activated/repressed genes has greatly enhanced our understanding of the mechanisms of Bordetella pathogenesis.

Entities:  

Mesh:

Year:  2001        PMID: 11689354     DOI: 10.2741/mattoo

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  47 in total

1.  Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract.

Authors:  Pascale Gueirard; Patrick Ave; Anne-Marie Balazuc; Sabine Thiberge; Michel Huerre; Genevieve Milon; Nicole Guiso
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains.

Authors:  Natacha Kourova; Valérie Caro; Christian Weber; Sabine Thiberge; Raisa Chuprinina; Galina Tseneva; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 3.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

4.  pagP is required for resistance to antibody-mediated complement lysis during Bordetella bronchiseptica respiratory infection.

Authors:  Mylisa R Pilione; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 5.  The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA.

Authors:  Kimberly B Decker; Tamara D James; Scott Stibitz; Deborah M Hinton
Journal:  Microbiology       Date:  2012-05-24       Impact factor: 2.777

6.  Mode of action of the Bordetella BvgA protein: transcriptional activation and repression of the Bordetella bronchiseptica bipA promoter.

Authors:  Meenu Mishra; Rajendar Deora
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

7.  Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin.

Authors:  Qing Guo; Yuequan Shen; Young-Sam Lee; Craig S Gibbs; Milan Mrksich; Wei-Jen Tang
Journal:  EMBO J       Date:  2005-09-01       Impact factor: 11.598

8.  The Bordetella bronchiseptica type III secretion system inhibits gamma interferon production that is required for efficient antibody-mediated bacterial clearance.

Authors:  Mylisa R Pilione; Eric T Harvill
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

Review 9.  Keeping their options open: acute versus persistent infections.

Authors:  S Furukawa; S L Kuchma; G A O'Toole
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

10.  Strain-dependent role of BrkA during Bordetella pertussis infection of the murine respiratory tract.

Authors:  Kelly D Elder; Eric T Harvill
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.